Better Health in Bangladesh (BHB)
Better Health in Bangladesh (BHB) is a project of MSH in Bangladesh. It is funded by the FCDO (Foreign, Commonwealth and Development Office, formerly DfID). BHB works for improvement of retail pharmaceuticals sector of Bangladesh and also provides technical assistance to the 4th health sector development program of the Ministry of Health and Family Welfare (MOHFW) of the Government of Bangladesh.
BHB in Action
Flexible TA support to MOHFW
BHB developed the (i) MIS for DGME, an provides and provided (ii) TAs for LDs/Planning Wing of MOHFW; (iii) Consultants for designing 5th HPNSP; and (iv) Event facilitation support, field visit, logistics and other support for HPNSP.
Policy engagement with DGDA
For the DGDA, BHB helped in the development of (i) Standards for Model Medicine Shops/ Model Pharmacies; (ii) Medicine Shop Accreditation System; and undertook activities for (iii) Promotion of Good Pharmacy Practice (GPP). Besides, BHB helped to develop (iv) Automated Drug Licensing
Multi-sectoral policy engagement for AMR
BHB conducts (i) campaigns for AMR, GPP, COVID-19, etc.; (ii) operates an eLearning platform to use as a potential knowledge transferring resource; and (iii) maintains an ICT system, renewal of web portal, software, plugins, Facebook, Blog, YouTube, etc. all for
BHB's Response for AMR
Tackling antimicrobial resistance in Bangladesh: A scoping review of policy and practice in human, animal and environment sectors
Background Antimicrobial resistance (AMR) has become an emerging issue in the developing countries as well as in Bangladesh. AMR is aggravated by irrational use of antimicrobials in a largely unregulated
Community engagement: The key to tackling Antimicrobial Resistance (AMR) across a One Health context?
Antimicrobial resistance (AMR) is a One Health problem underpinned by complex drivers and behaviours. This is particularly so in low – and middle-income countries (LMICs), where social and systemic factors
A bottom-up view of antimicrobial resistance transmission in developing countries
Antimicrobial resistance (AMR) is tracked most closely in clinical settings and high-income countries. However, resistant organisms thrive globally and are transmitted to and from healthy humans, animals and the environment,